Supremex Announces Appointment of Chief Financial Officer

Stock Information for Fennec Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Fennec Pharmaceuticals Inc.

Supremex Announces Results for the Third Quarter of 2025
Supremex Announces Date of Its 2025 Third Quarter Results Conference Call
Supremex Announces the Passing of a Company Director
Supremex Announces Results for the Second Quarter of 2025, a Special Dividend of $0.50 Per Common Share, the Renewal of Its Normal Course Issuer Bid and Completes Two Tuck-In Acquisitions Subsequent to the End of the Quarter
REPEAT - Supremex Announces Date of Its 2025 Second Quarter Results Conference Call
Supremex Announces Date of Its 2025 Second Quarter Results Conference Call
Supremex Completes Sale-Leaseback of Two Properties
Supremex Reports Voting Results from its Annual General Meeting

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.